Researchers are exploring a novel approach to gene therapy delivery by utilizing the body's natural communication system: extracellular vesicles, also known as exosomes. These naturally occurring bubbles, produced by cells, possess built-in targeting signals that direct them to specific cell types, overcoming the limitations of current gene-silencing drugs that primarily accumulate in the liver. This exosome-based method has shown significant promise in preclinical trials, effectively delivering gene-silencing cargo to target cells in the brain and kidneys of animal models with minimal side effects. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT This research could overcome major hurdles in gene therapy, enabling treatments for diseases beyond those affecting the liver.
RANK_REASON The cluster describes a novel research method for gene therapy delivery using extracellular vesicles, detailing preclinical trial results. [lever_c_demoted from research: ic=1 ai=0.4]
